IGFBP7 and metabolic dysfunction-associated steatotic liver disease: Functionally, IGFBP7 contributes to fibrogenesis by playing a role in the activation and transdifferentiation of hepatic stellate cells [21], and knockdown of IGFBP7 in mouse models of MASLD resulted in reduced insulin resistance and hepatic steatosis [22].